[go: up one dir, main page]

AU2001283957A1 - Treatment of ocular disorders with somatostatin analogues - Google Patents

Treatment of ocular disorders with somatostatin analogues

Info

Publication number
AU2001283957A1
AU2001283957A1 AU2001283957A AU8395701A AU2001283957A1 AU 2001283957 A1 AU2001283957 A1 AU 2001283957A1 AU 2001283957 A AU2001283957 A AU 2001283957A AU 8395701 A AU8395701 A AU 8395701A AU 2001283957 A1 AU2001283957 A1 AU 2001283957A1
Authority
AU
Australia
Prior art keywords
treatment
ocular disorders
somatostatin analogues
somatostatin
analogues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001283957A
Inventor
Kathrin Wyss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2001283957A1 publication Critical patent/AU2001283957A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/31Somatostatins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001283957A 2000-07-27 2001-07-25 Treatment of ocular disorders with somatostatin analogues Abandoned AU2001283957A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00116068 2000-07-27
EP00116068 2000-07-27
PCT/EP2001/008620 WO2002009739A1 (en) 2000-07-27 2001-07-25 Treatment of ocular disorders with somatostatin analogues

Publications (1)

Publication Number Publication Date
AU2001283957A1 true AU2001283957A1 (en) 2002-02-13

Family

ID=8169349

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001283957A Abandoned AU2001283957A1 (en) 2000-07-27 2001-07-25 Treatment of ocular disorders with somatostatin analogues

Country Status (2)

Country Link
AU (1) AU2001283957A1 (en)
WO (1) WO2002009739A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7189856B2 (en) 2001-12-28 2007-03-13 Gideon Shapiro Non-peptide somatostatin receptor ligands
ES2383303T3 (en) 2005-11-10 2012-06-20 Chemi S.P.A. Formulations of somatostatin analogue growth hormone prolonged release inhibitors
ES2362604B1 (en) * 2009-12-22 2012-06-28 Bcn Peptides, S.A. TYPICAL OPTIMAL FORMULATION OF PEPTIDES.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000006185A2 (en) * 1998-07-30 2000-02-10 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Methods of using lanreotide, a somatostatin analogue
CA2263042A1 (en) * 1999-02-25 2000-08-25 Robert W.A. Kuijpers Treatment of edema

Also Published As

Publication number Publication date
WO2002009739A1 (en) 2002-02-07

Similar Documents

Publication Publication Date Title
AU2002257936A1 (en) Methods of well treatment
GB0007193D0 (en) Treatment of movrmrnt disorders
AU2000260550A1 (en) Treatment of skin damage using polyenylphosphatidylcholine
AU2002303502A1 (en) Improved leads for the treatment of patients with chf
AU2002231206A1 (en) Treatment of depression
AU2001256855A1 (en) Preparation for the prevention and treatment of ocular disorders
AUPR074500A0 (en) Treatment of t cell disorders
AU2001260834A1 (en) The treatment of herpes
AU1356201A (en) Treatment of hyperproliferative disorders
AU2001251306A1 (en) Treatment of sleep disorders with hypocretin-1
AU2002319286A1 (en) Skin treatment
AU2002362505A1 (en) Compression sleeve for treatment of the extremities
AU7106300A (en) Treatment of skin disorders
AU2001283957A1 (en) Treatment of ocular disorders with somatostatin analogues
AU2080201A (en) Treatment of addiction disorders
AU2002327440A1 (en) Treatment of type i diabetes
AU2002210763A1 (en) Use of 1-ebio in the treatment of bipolar disorders
AU1405001A (en) Treatment of diseases
AU2001274446A1 (en) Vip-related peptides for the treatment of skin disorders
AU2001253560A1 (en) Methods of treatment
AU3582101A (en) The treatment of functional gastrointestinal disorders
HK1061528A (en) Novel arylaminopropane analogues and their use for the treatment of glaucoma
AU2001236361A1 (en) Treatment of asthma with lfm analogues
AU2002242293A1 (en) Treatment of neurological disease
AUPQ729000A0 (en) Treatment of damaged connective tissue